Phama Company Shares Rise Ahead of FDA Review
02 11월 2021 - 12:09AM
AllPennyStocks.com
After a surprising rejection in August, two pharma companies are
working toward approval ahead of their Type A meeting with the FDA
for a drug with significant potential
Medexus...
To read the full story on AllPennyStocks.com, click
here.
Medexus Pharmaceuticals (TSX:MDP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Medexus Pharmaceuticals (TSX:MDP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
